Completed PHASE4 INTERVENTIONAL NCT00331578

Multi-Center Registry Trial of EXCEL Biodegradable Polymer Drug-Eluting Stent (CREATE)

Sponsor: JW Medical Systems Ltd

Conditions AMI

Interventions Excel drug-eluting coronary artery stent

Updated 5 times since 2017 Last updated: Jan 19, 2009 Started: Jun 30, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates AMI and is currently completed. JW Medical Systems Ltd leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

JW Medical Systems Ltd

Data source: JW Medical Systems Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.